SBI Securities’s Pharvaris PHVS Stock Holding History

SBI Securities’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35	Hold	1	–	–	﹤0.01%	3748
2026 Q1	$28	Hold	1	–	–	﹤0.01%	3696
2025 Q4	$28	Sell	1 -2	-67%	-$48	﹤0.01%	3717
2025 Q3	$75	Buy	3 +2	+200%	+$44	﹤0.01%	3602
2025 Q2	$18	Hold	1	–	–	﹤0.01%	3932
2025 Q1	$16	Sell	1 -10	-91%	-$169	﹤0.01%	3903
2024 Q4	$211	Buy	+11	New	+$226	﹤0.01%	3224

Other funds holding PHVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

OCA

OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

SBI Securities's PHVS Position: Q2 2026 in Review

SBI Securities held its Pharvaris (PHVS) position steady in Q2 2026 at 1 share worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #3748.

SBI Securities first reported a position in PHVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $211 in Q4 2024. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

SBI Securities held 1 share of Pharvaris worth $35 as of Q2 2026.
SBI Securities left its Pharvaris share count unchanged in Q2 2026.
Pharvaris made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3748 holding.
SBI Securities first reported a position in Pharvaris in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Pharvaris position peaked at $211 in Q4 2024.
23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.